Literature DB >> 15163193

Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding.

Nguyen-Hai Nam1, Guofeng Ye, Gongqin Sun, Keykavous Parang.   

Abstract

A series of conformationally constrained peptides were designed and synthesized as the Src SH2 domain ligands based on a tetrapeptide sequence pTyr-Glu-Glu-Ile (pYEEI). In general, the constrained peptides such as compounds 6, 7, and 11 (IC(50) = 1.1-1.5 microM) showed higher binding affinities to the Src SH2 domain relative to the corresponding linear peptides 8a, 9a, and 13a, respectively (IC(50) > 100 microM), and pYEEI (IC(50) = 6.5 microM), as evaluated by a fluorescence polarization assay. Molecular modeling studies revealed that in constrained peptides, the isoleucine side chain penetrates very deeply into the hydrophobic binding pocket (P + 3 site) of the Src SH2 domain. These constrained peptides can serve as novel templates for the design of small and nonpeptidic inhibitors of the Src SH2 domain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163193     DOI: 10.1021/jm040008+

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

1.  Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design.

Authors:  Ryan N Gilbreth; Khue Truong; Ikenna Madu; Akiko Koide; John B Wojcik; Nan-Sheng Li; Joseph A Piccirilli; Yuan Chen; Shohei Koide
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  Peptide bicycles that inhibit the Grb2 SH2 domain.

Authors:  Justin S Quartararo; Pianpian Wu; Joshua A Kritzer
Journal:  Chembiochem       Date:  2012-06-11       Impact factor: 3.164

3.  Calculation of absolute protein-ligand binding free energy from computer simulations.

Authors:  Hyung-June Woo; Benoît Roux
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-02       Impact factor: 11.205

4.  Synthesis and structure-activity relationships of linear and conformationally constrained peptide analogues of CIYKYY as Src tyrosine kinase inhibitors.

Authors:  Anil Kumar; Guofeng Ye; Yuehao Wang; Xiaofeng Lin; Gongqin Sun; Keykavous Parang
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

Review 5.  Cyclization-activated prodrugs.

Authors:  Paula Gomes; Nuno Vale; Rui Moreira
Journal:  Molecules       Date:  2007-11-12       Impact factor: 4.411

6.  Synthesis and evaluation of tripodal peptide analogues for cellular delivery of phosphopeptides.

Authors:  Guofeng Ye; Nguyen-Hai Nam; Anil Kumar; Ali Saleh; Dinesh B Shenoy; Mansoor M Amiji; Xiaofeng Lin; Gongqin Sun; Keykavous Parang
Journal:  J Med Chem       Date:  2007-06-20       Impact factor: 7.446

Review 7.  Targeting kinase signaling pathways with constrained peptide scaffolds.

Authors:  Laura E Hanold; Melody D Fulton; Eileen J Kennedy
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

8.  Structural examination of ring-closing metathesis-derived 15-member macrocycles as Grb2 SH2 domain-binding tetrapeptide mimetics.

Authors:  Fa Liu; Karen M Worthy; Lakshman K Bindu; Robert J Fisher; Terrence R Burke
Journal:  J Org Chem       Date:  2007-11-09       Impact factor: 4.354

9.  Efficient delivery of cell impermeable phosphopeptides by a cyclic peptide amphiphile containing tryptophan and arginine.

Authors:  Amir Nasrolahi Shirazi; Rakesh Kumar Tiwari; Donghoon Oh; Antara Banerjee; Arpita Yadav; Keykavous Parang
Journal:  Mol Pharm       Date:  2013-04-15       Impact factor: 4.939

10.  Conformational determinants of phosphotyrosine peptides complexed with the Src SH2 domain.

Authors:  Joseph Nachman; Gerry Gish; Cristina Virag; Tony Pawson; Régis Pomès; Emil Pai
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.